GlaxoSmithKline's ViiV Healthcare Wins First FDA OK for Two-Drug HIV Regimen Post author:Sam Post published:November 21, 2017 Post category:BioPharma HIV patients have a new maintenance drug in their arsenal of medication. Source: BioSpace You Might Also Like HEALTHSOUTH Reports Strong Revenue And Earnings Growth For Fourth Quarter 2016 And Reiterates Full-Year 2017 Guidance February 21, 2017 19 Deaths, Serious Liver Injury Linked to Intercept Pharma's Ocaliva September 21, 2017 3 Drugs That Could Make-or-Break AbbVie February 11, 2018
HEALTHSOUTH Reports Strong Revenue And Earnings Growth For Fourth Quarter 2016 And Reiterates Full-Year 2017 Guidance February 21, 2017
